🇺🇸 FDA
Pipeline program

METHOTREXATE, METHOTREXATE, DESOXIMETASONE, TACROLIMUS, placebo, Acidum folicum Léčiva 10 mg obalené tablety, FOLIC ACID

MC-MTX.18/AD

Phase 3 small_molecule active

Quick answer

METHOTREXATE, METHOTREXATE, DESOXIMETASONE, TACROLIMUS, placebo, Acidum folicum Léčiva 10 mg obalené tablety, FOLIC ACID for moderate to severe atopic dermatitis is a Phase 3 program (small_molecule) at Medac Gesellschaft fuer klinische Spezialpraeparate mbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Medac Gesellschaft fuer klinische Spezialpraeparate mbH
Indication
moderate to severe atopic dermatitis
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials